Fig. 5 | Scientific Reports

Fig. 5

From: Impact of the COVID-19 pandemic on the epidemiology and molecular features of Pseudomonas aeruginosa bloodstream infections

Fig. 5

Comparative analysis of (a) non-susceptibility to 17 antipseudomonal agents tested in the 78 PA-BSI of pre-COVID (blue) and post-COVID (red) periods, and (b) resistance phenotypes detected in both periods: XDR (purple), MDR (light red) and non-MDR (light yellow).*p < 0.05. Abbreviations: PIP: piperacillin, TZP: piperacillin-tazobactam, CAZ: ceftazidime, FEP: cefepime, ATM: aztreonam, IPM: imipenem, MEM: meropenem, DOR: doripenem, GEN: gentamicin, TOB: tobramycin, AMK: amikacin, NET: netilmicin, CIP: ciprofloxacin, FDC: cefiderocol, CZA: ceftazidime-avibactam, C/T: ceftolozane-tazobactam, CST: colistin, XDR: extensively drug resistant, MDR: multidrug-resistant.

Back to article page